Enovis Corp reports results for the quarter ended March 31 - Earnings Summary

Enovis

08/05/2025 14:32

Enovis Corp ENOV.N reported quarterly adjusted earnings of 81 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 50 cents.  The mean expectation of eleven analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 71 cents to 78 cents per share.

Revenue rose 8.2% to $558.83 million from a year ago; analysts expected $558.90 million.

Enovis Corp's reported EPS for the quarter was a loss of 98 cents​.

The company reported a quarterly loss of $55.97 million.

Enovis Corp shares had fallen by 10.4% this quarter and lost 22.0% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 13.1% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Enovis Corp is $63.00

This summary was machine generated from LSEG data May 8 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
0.74
0.81
Beat
Dec. 31 2024
0.92
0.98
Beat
Sep. 30 2024
0.62
0.73
Beat
Jun. 30 2024
0.59
0.62
Beat